Letting patients decide when to stop antibiotics: a pilot study
NCT ID NCT06127160
First seen Jun 26, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This pilot study tested whether women with kidney infections could safely stop antibiotics once their symptoms resolved, instead of taking a full 10-day course. 35 women were randomly assigned to either standard treatment or a patient-directed approach. The main goal was to see if such a study is feasible and safe, not to prove effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cephalexin
- What this could lead to
- If successful, this could lead to shorter, more personalized antibiotic courses for kidney infections, reducing side effects and antibiotic resistance.
- What could go wrong
- This is a very small pilot study (35 participants) testing feasibility, not effectiveness. The approach may not work for everyone or could lead to higher relapse rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PYELONEPHRITIS ACUTE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Olive View - UCLA Medical Center
Sylmar, California, 91342, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.